Director at National Healthcare (NYSE: NHC) granted 7,500 stock options

Rhea-AI Filing Summary

National Healthcare Corp director William A. Adams received a grant of options on 7,500 shares of common stock. The options were granted on May 7, 2026 under the company’s 2020 Omnibus Equity Incentive Plan with a stated exercise price of $0.00 per share and expire on May 6, 2030. Following this award, Adams holds options covering 7,500 shares directly as reported in this filing. The grant and potential exercise are described as exempt from Section 16(b) under Rule 16b-3(d), indicating this is a routine equity-based compensation award for a board member.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Adams William A.

Role null

Type	Security	Shares	Price	Value
Grant/Award	Option to Purchase Common Stock [2026 Grant]	7,500	$0.00	--

Holdings After Transaction: Option to Purchase Common Stock [2026 Grant] — 7,500 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Options granted: 7,500 shares Exercise price: $0.00 per share Total options held after grant: 7,500 shares +2 more

5 metrics

Options granted 7,500 shares Options to purchase common stock granted May 7, 2026

Exercise price $0.00 per share Stated option exercise price for the 7,500-share grant

Total options held after grant 7,500 shares Total option shares following the reported transaction

Grant date May 7, 2026 Date options to purchase common stock were awarded

Expiration date May 6, 2030 Scheduled expiration of the granted stock options

Key Terms

2020 Omnibus Equity Incentive Plan, Section 16(b), Rule 16b-3(d), stock options

4 terms

2020 Omnibus Equity Incentive Plan financial

"These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026."

Section 16(b) regulatory

"The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d)."

A federal rule that requires company insiders—like officers, directors and large shareholders—to return any profits made from buying and selling the company’s stock within a six-month window. It matters to investors because it discourages short-term trades that could exploit non-public information and helps protect outside shareholders by creating a simple, enforceable way to recover unfair gains, much like a rule stopping someone from flipping a limited-edition item for quick profit after getting early access.

Rule 16b-3(d) regulatory

"The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d)."

stock options financial

"These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026."

Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Adams William A.

(Last) (First) (Middle)

100 VINE STREET

(Street)

MURFREESBORO TENNESSEE 37130

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTHCARE CORP [ NHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to Purchase Common Stock [2026 Grant]	$0	05/07/2026		A		7,500(1)		05/07/2026	05/06/2030	Common Stock	7,500	$0	7,500	D

Explanation of Responses:

1. These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).

	/s/ William A. Adams	05/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did NHC director William A. Adams report?

William A. Adams reported receiving a grant of stock options for 7,500 shares of National Healthcare Corp common stock. The award is a routine compensation grant made on May 7, 2026 under the company’s 2020 Omnibus Equity Incentive Plan.

What are the key terms of William A. Adams’ NHC stock option grant?

The grant covers options on 7,500 shares of National Healthcare Corp common stock with a stated exercise price of $0.00 per share. The options were granted May 7, 2026 and are scheduled to expire on May 6, 2030, providing a multi-year equity incentive.

Is William A. Adams’ NHC stock option grant considered a purchase or a compensation award?

The filing characterizes the transaction as a grant or award acquisition, not an open-market purchase. It is a derivative grant of options issued at $0.00 per share under the 2020 Omnibus Equity Incentive Plan, representing standard equity-based director compensation.

How many NHC options does William A. Adams hold after this reported grant?

After the reported transaction, William A. Adams holds options on 7,500 shares of National Healthcare Corp common stock directly. The total shares following the transaction shown in the filing match the 7,500 options granted in this award.

Under what plan were William A. Adams’ NHC stock options granted?

The options were granted pursuant to National Healthcare Corp’s 2020 Omnibus Equity Incentive Plan. This plan provides for equity-based awards to eligible participants, and the filing notes the grant is exempt from Section 16(b) under Rule 16b-3(d).